Yea Christopher Insider Trades

Insider Trading History

Track insider trading activity for Yea Christopher. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $0 0 shares
Last Trade
Jun 11, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$15.3M 567,188 shares
$27.00
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $0 0 shares
Last Trade
May 27, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$906k 33,800 shares
$26.79
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.21M 229,918 shares
Last Trade
May 27, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$905k 33,800 shares
$26.78
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $7.12M 263,718 shares
Last Trade
May 27, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$906k 33,800 shares
$26.79
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.21M 229,918 shares
Last Trade
May 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$52.6k 1,966 shares
$26.78
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.18M 228,759 shares
Last Trade
May 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$63.1k 2,358 shares
$26.78
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $675k 25,000 shares
Last Trade
May 22, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$83.7k 3,125 shares
$26.79
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.26M 231,884 shares
Last Trade
May 22, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$83.7k 3,125 shares
$26.79
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $1.11M 41,250 shares
Last Trade
May 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$100k 3,750 shares
$26.77
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.24M 231,117 shares
Last Trade
May 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$100k 3,750 shares
$26.77
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.14M 227,367 shares
Last Trade
May 18, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$29.7k 1,108 shares
$26.76
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.17M 228,475 shares
Last Trade
May 17, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$47.4k 1,774 shares
$26.73
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $0 0 shares
Last Trade
May 17, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$47.4k 1,774 shares
$26.73
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.12M 226,701 shares
Last Trade
Feb 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$67.7k 4,347 shares
$15.57
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $759k 28,125 shares
Last Trade
Feb 22, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49.5k 3,125 shares
$15.83
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.24M 231,048 shares
Last Trade
Feb 22, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49.5k 3,125 shares
$15.83
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.15M 227,923 shares
Last Trade
Feb 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$59.4k 3,750 shares
$15.83
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $1.22M 45,000 shares
Last Trade
Feb 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$59.4k 3,750 shares
$15.83
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.05M 224,173 shares
Last Trade
Feb 18, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.6k 1,109 shares
$15.00
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.08M 225,282 shares
Last Trade
Feb 17, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.6k 1,774 shares
$14.99
$27.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up